General MedicationsORALStandard

CODEINE SULFATE

Standard Dose

30MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Prescription

Summary

Approval overview CODEINE SULFATE is listed in Drugs@FDA under application 203046 (ANDA).

Marketing status: Prescription Active ingredient CODEINE SULFATE Form and strength TABLET;ORAL - 30MG Sponsor LANNETT CO INC Submission history Latest submission status date: 2024-10-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview CODEINE SULFATE is listed in Drugs@FDA under application 203046 (ANDA). Marketing status: Prescription Active ingredient CODEINE SULFATE Form and strength TABLET;ORAL - 30MG Sponsor LANNETT CO INC Submission history Latest submission status date: 2024-10-31 00:00:00. Submission type: SUPPL.

Monitoring

• Review priority: STANDARD
• Marketing status: Prescription

Interaction Notes

No interaction notes stored yet.